The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Carcinoma of unknown primary site (CUP): Outcomes in patients with a colorectal molecular profile treated with site-specific chemotherapy.
F. A. Greco
Honoraria - bioTheranostics
W. J. Lennington
No relevant relationships to disclose
D. R. Spigel
No relevant relationships to disclose
G. R. Varadhachary
No relevant relationships to disclose
J. D. Hainsworth
No relevant relationships to disclose